James Harron Bloodstock And Tony Fung Investments Partner For 2025 Yearling Sales

[Wandering Eyes]

James Harron Bloodstock (JHB) and Tony Fung Investments (TFI) will partner for the 2025 yearling sales. TFI will participate in acquisitions for both the JHB Colt Partnership and the JHB/Michael Freedman Filly Partnership.

“As the market continues to evolve, so must we,” said James Harron in a statement. “Historically, we've been fierce competitors in the sales ring with Tony and his team. However, given our shared focus on acquiring and developing elite horses to maximize on-sale value and build enduring stallion equity for our partners, this partnership is a natural next step. I have tremendous respect for the achievements of Tony and his team, and believe this alliance represents a great opportunity for all involved.”

The two companies have previously purchased (separately) G1 Golden Slipper winners Capitalist (Aus) and Farnan (Aus), dual Group 1 winner King's Legacy (Aus), as well as group winning stallions Prague (Aus) and Anders (Aus).

“When I first landed in Australia, I asked my team who was the competitor we ought both fear, and look to for inspiration, and my team unequivocally said the team at James Harron Bloodstock,” said John Fung, Tony Fung's son. “Over the November sales in Kentucky, our teams began developing the idea to combine our energies and maximize value for the foreseeable future. Today, I am thrilled that we have found our way to this exciting collaboration. I look forward to learning from James and his team over the next few years, and to all the opportunities which the upcoming sales present. I truly think that my family's future in this industry has been enhanced by this partnership.”

The post James Harron Bloodstock And Tony Fung Investments Partner For 2025 Yearling Sales appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

View the full article